The Nuclear Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.globalinforesearch.com/reports/696087/nuclear-medicine
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nuclear Medicine market size is estimated to be worth US$ 6368.4 million in 2021 and is forecast to a readjusted size of USD 10280 million by 2028 with a CAGR of 7.1% during review period. Diagnostic accounting for % of the Nuclear Medicine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tc-99 segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Nuclear Medicine include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, and Bayer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nuclear Medicine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others
Market segment by Application, can be divided into
Diagnostic
Therapeutic
Market segment by players, this report covers
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nuclear Medicine, with price, sales, revenue and global market share of Nuclear Medicine from 2019 to 2022.
Chapter 3, the Nuclear Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, end user, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nuclear Medicine market forecast, by regions, type and end user, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nuclear Medicine.
Chapter 13, 14, and 15, to describe Nuclear Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
About Us:
GlobaI Info Research（GIR） is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Nuclear Medicine
1.2 Classification of Nuclear Medicine by Type
1.2.1 Overview: Global Nuclear Medicine Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Nuclear Medicine Revenue Market Share by Type in 2021
1.2.3 Tc-99
1.2.4 I-123/131
1.2.5 In-111
1.2.6 Xe-133
1.2.7 Th-201
1.2.8 Ga-67
1.2.9 Others
1.3 Global Nuclear Medicine Market by Application
1.3.1 Overview: Global Nuclear Medicine Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Global Nuclear Medicine Market Size & Forecast
1.5 Global Nuclear Medicine Market Size and Forecast by Region
1.5.1 Global Nuclear Medicine Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Nuclear Medicine Market Size by Region, (2017-2022)
1.5.3 North America Nuclear Medicine Market Size and Prospect (2017-2028)
1.5.4 Europe Nuclear Medicine Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Nuclear Medicine Market Size and Prospect (2017-2028)
1.5.6 South America Nuclear Medicine Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Nuclear Medicine Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Nuclear Medicine Market Drivers
1.6.2 Nuclear Medicine Market Restraints
1.6.3 Nuclear Medicine Trends Analysis
2 Company Profiles
2.1 GE Healthcare
2.1.1 GE Healthcare Details
2.1.2 GE Healthcare Major Business
2.1.3 GE Healthcare Nuclear Medicine Product and Solutions
2.1.4 GE Healthcare Nuclear Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 GE Healthcare Recent Developments and Future Plans
2.2 Bracco Imaging
2.2.1 Bracco Imaging Details
2.2.2 Bracco Imaging Major Business
2.2.3 Bracco Imaging Nuclear Medicine Product and Solutions
2.2.4 Bracco Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Bracco Imaging Recent Developments and Future Plans
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Nuclear Medicine Product and Solutions
2.3.4 Mallinckrodt Nuclear Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Mallinckrodt Recent Developments and Future Plans
2.4 Lantheus Medical Imaging
2.4.1 Lantheus Medical Imaging Details
2.4.2 Lantheus Medical Imaging Major Business
2.4.3 Lantheus Medical Imaging Nuclear Medicine Product and Solutions
2.4.4 Lantheus Medical Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Lantheus Medical Imaging Recent Developments and Future Plans
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Nuclear Medicine Product and Solutions
2.5.4 Bayer Nuclear Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Bayer Recent Developments and Future Plans
2.6 Triad Isotopes
2.6.1 Triad Isotopes Details
2.6.2 Triad Isotopes Major Business
2.6.3 Triad Isotopes Nuclear Medicine Product and Solutions
2.6.4 Triad Isotopes Nuclear Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Triad Isotopes Recent Developments and Future Plans
2.7 Nordion
2.7.1 Nordion Details
2.7.2 Nordion Major Business
2.7.3 Nordion Nuclear Medicine Product and Solutions
2.7.4 Nordion Nuclear Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Nordion Recent Developments and Future Plans
2.8 Jubilant Pharma
2.8.1 Jubilant Pharma Details
2.8.2 Jubilant Pharma Major Business
2.8.3 Jubilant Pharma Nuclear Medicine Product and Solutions
2.8.4 Jubilant Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Jubilant Pharma Recent Developments and Future Plans
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Nuclear Medicine Product and Solutions
2.9.4 Eli Lilly Nuclear Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Eli Lilly Recent Developments and Future Plans
2.10 SIEMENS
2.10.1 SIEMENS Details
2.10.2 SIEMENS Major Business
2.10.3 SIEMENS Nuclear Medicine Product and Solutions
2.10.4 SIEMENS Nuclear Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 SIEMENS Recent Developments and Future Plans
2.11 China Isotope & Radiation
2.11.1 China Isotope & Radiation Details
2.11.2 China Isotope & Radiation Major Business
2.11.3 China Isotope & Radiation Nuclear Medicine Product and Solutions
2.11.4 China Isotope & Radiation Nuclear Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 China Isotope & Radiation Recent Developments and Future Plans
2.12 Dongcheng
2.12.1 Dongcheng Details
2.12.2 Dongcheng Major Business
2.12.3 Dongcheng Nuclear Medicine Product and Solutions
2.12.4 Dongcheng Nuclear Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Dongcheng Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Nuclear Medicine Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Nuclear Medicine Players Market Share in 2021
3.2.2 Top 10 Nuclear Medicine Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Nuclear Medicine Players Head Office, Products and Services Provided
3.4 Nuclear Medicine Mergers & Acquisitions
3.5 Nuclear Medicine New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Nuclear Medicine Revenue and Market Share by Type (2017-2022)
4.2 Global Nuclear Medicine Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Nuclear Medicine Revenue Market Share by Application (2017-2022)
5.2 Global Nuclear Medicine Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Nuclear Medicine Revenue by Type (2017-2028)
6.2 North America Nuclear Medicine Revenue by Application (2017-2028)
6.3 North America Nuclear Medicine Market Size by Country
6.3.1 North America Nuclear Medicine Revenue by Country (2017-2028)
6.3.2 United States Nuclear Medicine Market Size and Forecast (2017-2028)
6.3.3 Canada Nuclear Medicine Market Size and Forecast (2017-2028)
6.3.4 Mexico Nuclear Medicine Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Nuclear Medicine Revenue by Type (2017-2028)
7.2 Europe Nuclear Medicine Revenue by Application (2017-2028)
7.3 Europe Nuclear Medicine Market Size by Country
7.3.1 Europe Nuclear Medicine Revenue by Country (2017-2028)
7.3.2 Germany Nuclear Medicine Market Size and Forecast (2017-2028)
7.3.3 France Nuclear Medicine Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Nuclear Medicine Market Size and Forecast (2017-2028)
7.3.5 Russia Nuclear Medicine Market Size and Forecast (2017-2028)
7.3.6 Italy Nuclear Medicine Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Nuclear Medicine Revenue by Type (2017-2028)
8.2 Asia-Pacific Nuclear Medicine Revenue by Application (2017-2028)
8.3 Asia-Pacific Nuclear Medicine Market Size by Region
8.3.1 Asia-Pacific Nuclear Medicine Revenue by Region (2017-2028)
8.3.2 China Nuclear Medicine Market Size and Forecast (2017-2028)
8.3.3 Japan Nuclear Medicine Market Size and Forecast (2017-2028)
8.3.4 South Korea Nuclear Medicine Market Size and Forecast (2017-2028)
8.3.5 India Nuclear Medicine Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Nuclear Medicine Market Size and Forecast (2017-2028)
8.3.7 Australia Nuclear Medicine Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Nuclear Medicine Revenue by Type (2017-2028)
9.2 South America Nuclear Medicine Revenue by Application (2017-2028)
9.3 South America Nuclear Medicine Market Size by Country
9.3.1 South America Nuclear Medicine Revenue by Country (2017-2028)
9.3.2 Brazil Nuclear Medicine Market Size and Forecast (2017-2028)
9.3.3 Argentina Nuclear Medicine Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Nuclear Medicine Revenue by Type (2017-2028)
10.2 Middle East & Africa Nuclear Medicine Revenue by Application (2017-2028)
10.3 Middle East & Africa Nuclear Medicine Market Size by Country
10.3.1 Middle East & Africa Nuclear Medicine Revenue by Country (2017-2028)
10.3.2 Turkey Nuclear Medicine Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Nuclear Medicine Market Size and Forecast (2017-2028)
10.3.4 UAE Nuclear Medicine Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Contact US
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
WeChat: 17665052062
Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG
Website: http://www.globalinforesearch.com
No comments:
Post a Comment